eValuating iDA Selection Ability. The VISA Study.

NCT ID: NCT04969822

Last Updated: 2024-12-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1066 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-20

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IVF Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Embryo selection by standard morphologic criteria

The embryo for transfer will be selected by the embryologist on the basis of the morphologic appearances on day 5, according to the Gardner criteria using the ranking guideline.

Group Type NO_INTERVENTION

No interventions assigned to this group

Embryo selection by iDA

Time-lapse videos will be analyzed by iDA and the embryo for fresh transfer on day 5 will be prioritized on the strict basis of the embryo with the highest iDA score. For a frozen cycle; the first embryo to be warmed will be the one with the highest iDA score.

Group Type EXPERIMENTAL

iDAScore®

Intervention Type DEVICE

A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iDAScore®

A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins and the intention to treat by either transfer of a single fresh embryo on day 5 or in case of a freeze all cycle, the first rewarmed embryo.
2. Age: Up to and including the 42nd completed birthday on the day of randomization.
3. Has at least two early blastocysts on day 5.

Exclusion Criteria

1. Treatment involving donated eggs
2. Intention to perform any form of preimplantation genetic testing
3. The use of IMSI or polarized light in the ICSI process
4. The use of assisted hatching prior to randomization
5. Previous participation in this RCT
6. Where the cycle is carried out for fertility preservation
7. If a day 2-4 transfer is planned
8. Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by either: an AMH level of \<3pmol/L or AFC \<5 (if available)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vitrolife

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Illingworth, A/Prof

Role: PRINCIPAL_INVESTIGATOR

Virtus Health, Sydney, Australia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IVFAustralia Greenwich

Sydney, Greenwich, Australia

Site Status

IVFAustralia Alexandria

Alexandria, New South Wales, Australia

Site Status

IVFAustralia, Westmead

Sydney, New South Wales, Australia

Site Status

Queensland Fertility Group (QFG)

Benowa, Queensland, Australia

Site Status

Melbourne IVF

East Melbourne, Victoria, Australia

Site Status

Universitetshospitalet

Aalborg, , Denmark

Site Status

Aagaard Fertilitetsklinik

Aarhus, , Denmark

Site Status

Regionshospitalet

Horsens, , Denmark

Site Status

Livio Gothenburg

Gothenburg, , Sweden

Site Status

Reproductive medicine, Sahlgrenska University Hospital

Gothenburg, , Sweden

Site Status

Thames Valley Fertility (TFP)

Maidenhead, , United Kingdom

Site Status

Nurture Fertility (TFP)

Nottingham, , United Kingdom

Site Status

Oxford Fertility (TFP)

Oxford, , United Kingdom

Site Status

Wessex Fertility (TFP)

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Denmark Sweden United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Illingworth PJ, Venetis C, Gardner DK, Nelson SM, Berntsen J, Larman MG, Agresta F, Ahitan S, Ahlstrom A, Cattrall F, Cooke S, Demmers K, Gabrielsen A, Hindkjaer J, Kelley RL, Knight C, Lee L, Lahoud R, Mangat M, Park H, Price A, Trew G, Troest B, Vincent A, Wennerstrom S, Zujovic L, Hardarson T. Deep learning versus manual morphology-based embryo selection in IVF: a randomized, double-blind noninferiority trial. Nat Med. 2024 Nov;30(11):3114-3120. doi: 10.1038/s41591-024-03166-5. Epub 2024 Aug 9.

Reference Type RESULT
PMID: 39122964 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1571 - VISA

Identifier Type: -

Identifier Source: org_study_id